13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 64 holding rows worth $4,180,807,000.
- Accession
- 0001104659-20-021735
- Filer
- CIK 1425738
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 64 entries on the cover page, a total value of $4,180,807,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,180,807,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 4,709,498 | $293,119,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 3,033,526 | $289,277,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 25,209,964 | $245,545,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 11,216,809 | $219,513,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 8,746,033 | $215,152,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 1,153,232 | $185,117,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 2,553,325 | $182,971,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 2,722,388 | $149,132,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 457,500 | $135,754,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 3,144,000 | $119,975,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 1,800,800 | $115,593,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 939,164 | $110,389,000 | thousands by filing date | |
| FORTY SEVEN INC | 34983P104 | COM | 2,770,842 | $109,088,000 | thousands by filing date | |
| APREA THERAPEUTICS INC | 03836J102 | COM | 2,268,718 | $104,111,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 2,508,386 | $102,769,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 1,552,598 | $97,612,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 2,129,100 | $80,352,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 4,648,570 | $76,562,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 14,639,960 | $74,737,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,631,200 | $73,763,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 1,172,232 | $69,877,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 3,237,700 | $63,880,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 1,090,200 | $60,375,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 203,100 | $59,707,000 | thousands by filing date | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 573,100 | $54,267,000 | thousands by filing date | |
| PRA HEALTH SCIENCES INC | 69354M108 | COM | 449,800 | $49,995,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 1,532,000 | $42,452,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 285,200 | $42,155,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 859,526 | $41,283,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 701,178 | $40,241,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 2,766,407 | $39,698,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 2,940,889 | $38,761,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 639,095 | $38,243,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 389,700 | $30,451,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 100,800 | $30,445,000 | thousands by filing date | |
| AMEDISYS INC | 023436108 | COM | 181,065 | $30,223,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 147,500 | $30,162,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 4,000,000 | $30,020,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,020,778 | $28,908,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 3,116,594 | $27,956,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 3,326,493 | $26,662,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 1,164,002 | $25,835,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 1,799,188 | $25,692,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 790,071 | $25,638,000 | thousands by filing date | |
| SHOCKWAVE MED INC | 82489T104 | COM | 567,900 | $24,942,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 1,920,831 | $23,665,000 | thousands by filing date | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 1,892,521 | $23,146,000 | thousands by filing date | |
| XERIS PHARMACEUTICALS INC | 98422L107 | COM | 3,000,641 | $21,155,000 | thousands by filing date | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 936,700 | $20,917,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,431,696 | $20,001,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 1,136,806 | $17,586,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 3,169,308 | $16,766,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 613,734 | $16,221,000 | thousands by filing date | |
| CRYOPORT INC COM PAR $0.001 | 229050307 | Stock | 842,363 | $13,865,000 | thousands by filing date | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 425,700 | $12,737,000 | thousands by filing date | |
| VAPOTHERM INC | 922107107 | COM | 959,539 | $11,668,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 1,343,845 | $7,109,000 | thousands by filing date | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 173,500 | $5,878,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,813,565 | $5,515,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 260,300 | $4,068,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 212,291 | $1,467,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 121,950 | $506,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S304 | COM NEW | 78,755 | $124,000 | thousands by filing date | |
| CASTLIGHT HEALTH INC CL B | 14862Q100 | Stock | 10,229 | $14,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-20-021735 | this filing | 2020-02-14 | acceptance time not in the bulk data set |